drugset / Trial / NCT01204840
Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if growth hormone given 4 weeks before as well as during a cycle of in vitro fertilization will improve outcomes in women who have had previous failure with IVF treatment cycles using high doses of follicle stimulating medications and had a poor response (less than 6 follicles).
Timeline
- Start
- 2010-09
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 3.33 mg | Subcutaneous |
| Comparator | Cetrorelix | Other / unclassified | 0.25 mg | — |
| Comparator | Estradiol | Other / unclassified | 100 ug | Other |
| Comparator | Gonal-f | Protein / enzyme biologic | 412 iu | — |
| Comparator | Luveris | Protein / enzyme biologic | 150 iu | — |
| Comparator | Progesterone | Other / unclassified | 100 mg | Other |
| Comparator | human chorionic gonadotropin | Protein / enzyme biologic | 10000 iu | — |